This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Myriad Pharmaceuticals, Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Yevgeniya I Klimova: Innovator in Neurodegenerative Disorder Treatments
Introduction
Yevgeniya I Klimova is a notable inventor based in Salt Lake City, UT, who has made significant contributions to the field of therapeutic compounds. With a focus on neurodegenerative disorders, her work aims to address critical health challenges faced by many individuals.
Latest Patents
Klimova holds a patent for "Pyrrole derivatives as therapeutic compounds." This innovative patent discloses novel pyrrole derivatives that serve as Aβ-lowering agents for the treatment and prevention of neurodegenerative disorders characterized by the formation or accumulation of amyloid plaques comprising the Aβ peptide. This advancement has the potential to impact the treatment landscape for conditions such as Alzheimer's disease.
Career Highlights
Klimova is currently associated with Myriad Pharmaceuticals, Inc., where she continues to develop her research and innovations. Her work is characterized by a commitment to improving therapeutic options for patients suffering from debilitating neurodegenerative conditions.
Collaborations
Some of her notable coworkers include Warren S Weiner and Rachel M Slade, who contribute to the collaborative environment that fosters innovation and research excellence.
Conclusion
Yevgeniya I Klimova's contributions to the field of therapeutic compounds highlight her dedication to addressing neurodegenerative disorders. Her innovative work and collaborations position her as a key figure in the ongoing quest for effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile